A phase 2 study of K-134 in patients with intermittent claudication

A phase 2 study to evaluate the efficacy and safety of K-134 for the treatment of intermittent claudication

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221661

Enrollment

330

Registered

2011-12-01

Start date

2011-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral arterial disease

Interventions

investigational material(s) Generic name etc : K-134 INN of investigational material : Therapeutic category code : 217 Vasodilators Dosage and Administration for Investigational material : Oral cont

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with intermittent claudication secondary to peripheral arterial disease

Exclusion criteria

Exclusion criteria: Patients with critical limb ischemia, patients with congestive heart failure

Design outcomes

Primary

Measure	Time frame
Peak walking time Treadmill test	—

Secondary

Measure	Time frame
Claudication onset time Treadmill test	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026